Every living thing — from a bacterium invisible to the naked eye to a blue whale — is built from the same fundamental unit: the cell. Cell biology is the bedrock of modern biotechnology, genetic engineering, vaccine development, and medicine, all of which appear regularly in UPSC GS3. Questions on GMO crops, stem cell therapy, CRISPR gene editing, and organ transplantation all require a sound understanding of what cells are and how they function. This chapter provides that foundation with Prelims-ready facts and Mains-level conceptual clarity.
PART 1 — Quick Reference Tables
Cell Theory — Three Propositions
| Scientist | Contribution | Year |
|---|---|---|
| Matthias Schleiden | All plants are made of cells | 1838 |
| Theodor Schwann | All animals are made of cells | 1839 |
| Rudolf Virchow | New cells arise only from pre-existing cells (Omnis cellula e cellula) | 1855 |
Prokaryote vs Eukaryote
| Feature | Prokaryote | Eukaryote |
|---|---|---|
| Nucleus | No membrane-bound nucleus; nucleoid region only | True membrane-bound nucleus |
| Size | 1–10 µm | 10–100 µm |
| DNA | Circular, no histones | Linear chromosomes with histones |
| Organelles | No membrane-bound organelles | Membrane-bound organelles present |
| Cell division | Binary fission | Mitosis/meiosis |
| Examples | Bacteria, Archaea, Cyanobacteria | Plants, animals, fungi, protists |
Plant Cell vs Animal Cell — Key Differences
| Feature | Plant Cell | Animal Cell |
|---|---|---|
| Cell wall | Present (cellulose) | Absent |
| Chloroplast | Present | Absent |
| Vacuole | Large central vacuole | Small, scattered vacuoles |
| Centrosome | Generally absent | Present |
| Lysosomes | Rarely found | Common |
| Shape | Fixed, rectangular | Variable, irregular |
| Plastids | Present | Absent |
Cell Organelles — Summary Table
| Organelle | Found In | Key Function |
|---|---|---|
| Nucleus | Both | Controls all cellular activities; contains DNA |
| Mitochondria | Both | ATP production; "powerhouse of the cell" |
| Chloroplast | Plants only | Photosynthesis; contains chlorophyll |
| Endoplasmic Reticulum (RER) | Both | Protein synthesis and transport (rough ER) |
| Endoplasmic Reticulum (SER) | Both | Lipid synthesis, detoxification (smooth ER) |
| Golgi Apparatus | Both | Packaging and secretion of proteins |
| Ribosome | Both | Protein synthesis (translation of mRNA) |
| Lysosome | Animals mainly | Intracellular digestion; waste disposal |
| Vacuole | Both (large in plants) | Storage of water, food, waste; turgor |
| Centrosome/Centriole | Animals | Cell division (spindle fibre formation) |
| Plasma Membrane | Both | Selective permeability; regulates entry/exit |
| Cell Wall | Plants, Fungi | Protection; gives shape; made of cellulose (plants) |
PART 2 — Detailed Notes
1. The Cell: Discovery and Theory
The cell was first observed by Robert Hooke in 1665 using a primitive microscope when he examined thin slices of cork — he called the box-like structures "cells." Anton van Leeuwenhoek later observed living cells (bacteria and protists) in pond water.
Cell theory, consolidated by Schleiden, Schwann and Virchow, establishes three foundational truths:
- All living organisms are composed of cells and products of cells.
- The cell is the basic structural and functional unit of life.
- All cells arise from pre-existing cells.
💡 Explainer: Why Cell Theory Matters for UPSC
Cell theory is directly relevant to debates about what constitutes "life." It underpins questions on:
- Whether viruses are "living" (they lack cellular structure — viruses cannot replicate independently)
- Stem cell research and ethics (stem cells are undifferentiated cells capable of becoming any cell type)
- Definition of death for organ donation purposes (cell death vs brain death)
2. Prokaryotic and Eukaryotic Cells
Prokaryotic cells (pro = before; karyon = nucleus) are simpler and evolutionarily older. Bacteria are the dominant prokaryotes. Their DNA floats in a region called the nucleoid without a membrane. They lack all membrane-bound organelles except ribosomes.
Eukaryotic cells have a true nucleus bounded by a nuclear envelope with nuclear pores. Their organelles are compartmentalised, allowing specialised biochemical reactions to occur simultaneously without interference.
3. Cell Organelles in Detail
Nucleus: The control centre of the cell. The nucleus contains chromosomes made of chromatin (DNA + proteins). The nucleolus inside the nucleus synthesises rRNA. The nuclear envelope has pores allowing controlled exchange of molecules between nucleus and cytoplasm.
Mitochondria: Double-membrane organelle. The outer membrane is smooth; the inner membrane is folded into cristae, which increase surface area for ATP synthesis. The matrix inside contains its own DNA (mtDNA), RNA and ribosomes — evidence that mitochondria evolved from ancient bacteria (endosymbiotic theory). ATP is produced by oxidative phosphorylation.
Chloroplast: Found in green parts of plants. Also double-membrane. Inner membrane system forms flattened thylakoids stacked into grana. The fluid outside grana is stroma. Light reactions (photosystems I and II) occur in thylakoid membranes; the Calvin cycle (dark reactions) occurs in the stroma. Like mitochondria, chloroplasts have their own DNA.
Endoplasmic Reticulum: A network of membranous tubes and sheets. Rough ER (RER) is studded with ribosomes and synthesises proteins destined for secretion or membranes. Smooth ER (SER) lacks ribosomes and synthesises lipids and steroids; in liver cells it detoxifies drugs and poisons.
Golgi Apparatus: Named after Camillo Golgi (1898). A stack of flattened membrane sacs (cisternae). Receives proteins from ER, modifies them (adds sugars, phosphates), sorts and packages them into vesicles for secretion outside the cell or delivery to lysosomes. Functions as the cell's "post office."
Ribosomes: Tiny, non-membrane-bound granules composed of rRNA and proteins. Prokaryotic ribosomes are 70S (30S + 50S subunits); eukaryotic are 80S (40S + 60S). This difference is exploited by antibiotics — drugs like streptomycin and erythromycin target 70S ribosomes of bacteria without harming human 80S ribosomes.
Lysosomes: Membrane sacs filled with hydrolytic enzymes (lipases, proteases, nucleases). They digest worn-out organelles, bacteria, and food particles. If lysosomes burst inside the cell, they digest the cell itself — hence called "suicide bags." Important in immune cells (macrophages) that engulf pathogens.
Vacuoles: In plant cells, a large central vacuole may occupy 80–90% of the cell volume. It maintains turgor pressure (the rigidity of plant cells), stores water, pigments, toxins and waste products. In animal cells, contractile vacuoles expel excess water (in freshwater protists).
Centrosome: Found in animal cells and lower plants. Contains two centrioles at right angles. During cell division, centrosomes organise the spindle apparatus that pulls chromosomes apart. Plant cells lack centrioles but can still form spindle fibres using other structures.
4. Plasma Membrane — Selective Permeability
The plasma membrane is a fluid mosaic of phospholipids (bilayer) embedded with proteins. It is selectively permeable — it allows some molecules to pass freely while restricting others.
Passive transport (no energy required):
- Diffusion: Movement of molecules from high concentration to low concentration (e.g., CO2 out of cells).
- Osmosis: Diffusion of water molecules through a semi-permeable membrane from a region of lower solute concentration (higher water potential) to a region of higher solute concentration (lower water potential).
Active transport (energy/ATP required): Movement against the concentration gradient using carrier proteins. Example: Na+-K+ pump in nerve cells.
💡 Explainer: Osmosis in Action
- Hypotonic solution (solute concentration outside < inside cell): Water enters the cell. Animal cell swells and may burst (lysis); plant cell becomes turgid — this is the normal healthy state (turgor).
- Hypertonic solution (solute concentration outside > inside cell): Water leaves the cell. Animal cell shrinks (crenation); plant cell shrinks and the plasma membrane pulls away from cell wall — this is plasmolysis.
- Isotonic solution: No net movement; cell remains the same size.
Plasmolysis is the shrinkage of the protoplast (living matter) away from the cell wall when a plant cell is placed in a hypertonic solution. It is reversible — returning the cell to a hypotonic solution causes deplasmolysis.
5. Movement Across Membranes — Summary
Three types of solutions and their effects:
Hypotonic → cell gains water → plant cell turgid, animal cell bursts Isotonic → no net water movement → normal animal cell shape Hypertonic → cell loses water → plant cell plasmolysed, animal cell crenated
PART 3 — Frameworks & Analysis
Framework: Cell Biology → Biotechnology Applications
Understanding cell organelles directly underpins modern biotechnology:
| Cell Component | Biotechnology Application |
|---|---|
| Nucleus / DNA | Genetic engineering, CRISPR-Cas9 gene editing, GMO crops |
| Ribosome | Antibiotic targets (aminoglycosides, macrolides, chloramphenicol) |
| Mitochondrial DNA | Maternal lineage tracing; forensic identification |
| Chloroplast DNA | Plastid genetic engineering; herbicide-resistant crops |
| Lysosomes | Lysosomal storage disease research; enzyme replacement therapy |
| Cell membrane | Drug delivery systems; liposome encapsulation for medicine |
[Additional] CRISPR-Cas9 Gene Editing — The "Molecular Scissors"
What is CRISPR-Cas9? CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a natural bacterial immune system. Scientists repurposed it as a precise gene-editing tool: a guide RNA (gRNA) directs the Cas9 enzyme to a specific DNA sequence in the nucleus → Cas9 cuts the DNA → the cell's own repair machinery either disables the gene (gene knockout) or replaces it with a new sequence (gene insertion). Unlike traditional GMOs (which insert foreign genes from another species), CRISPR can make precise edits to the plant's own existing genes — no foreign DNA.
Nobel Prize 2020: Jennifer Doudna (USA) and Emmanuelle Charpentier (France) won the Nobel Prize in Chemistry for developing CRISPR-Cas9 as an editing tool.
CRISPR vs Traditional GM crops — regulatory significance:
| Feature | Traditional GM (e.g., Bt cotton) | CRISPR Genome Editing |
|---|---|---|
| Foreign DNA inserted? | Yes (from another species) | No (own genes edited) |
| India's regulation | GEAC approval required (GMO rules) | Exempt from GEAC if no foreign DNA (2022 guidelines) |
| Approval time | ~10+ years | Faster track |
| UPSC angle | Bt cotton, Bt brinjal controversy | New regulatory paradigm |
India's genome editing regulation (2022 Guidelines, MoEFCC/DBT): India exempted SDN-1 and SDN-2 genome-edited varieties (no foreign DNA) from the stringent GMO regulatory pathway, placing them under a faster review process by ICAR/DBT.
India's first genome-edited crops approved (May 2025, ICAR): Two rice varieties approved after multi-location trials:
- GE Samba Mahsuri — 19% average yield increase
- GE MTU-1010 — tolerance to saline and alkaline soils (critical for coastal and Indo-Gangetic plain areas)
Why this matters for UPSC: The CRISPR/genome-editing regulatory distinction is already appearing in exam questions — it shows India is creating a separate policy space for new breeding techniques that are faster and cheaper than traditional GM regulation, addressing food security without the controversy of foreign-gene insertion.
Framework: Endosymbiotic Theory
Both mitochondria and chloroplasts have their own circular DNA, 70S ribosomes (prokaryotic type), double membranes, and can reproduce by binary fission. This evidence supports the endosymbiotic theory (Lynn Margulis, 1967): eukaryotic cells evolved when large prokaryotes engulfed smaller ones that became permanent symbionts.
Significance for UPSC: This theory is evidence that evolution occurs at the cellular level and explains why these organelles are targets for certain antibiotics.
[Additional] 5a. Antimicrobial Resistance — From Ribosome Science to India's AMR Crisis
The chapter explains that antibiotics target 70S ribosomes of bacteria — but stops there. The policy dimension is absent: why misuse of antibiotics at scale converts this cellular mechanism into a global health emergency, and what India is doing about it.
How AMR arises from cellular mechanisms: Bacteria reproduce by binary fission — a single cell can produce billions of offspring in hours. During replication, random mutations occur in DNA. If a mutation alters the ribosome or a cell-membrane protein so that an antibiotic can no longer bind effectively, that bacterium survives and multiplies while antibiotic-sensitive bacteria die. The resistant strain rapidly dominates. Bacteria also transfer resistance genes horizontally (between different bacterial cells, even across species) via plasmids — small circular DNA fragments that pass directly between cells. This means resistance spreads far faster than evolution alone would allow.
The result: Antibiotics that once killed bacteria in 24 hours now fail. Drug-resistant infections become untreatable — routine surgeries, cancer chemotherapy, organ transplants (which suppress immunity) all become catastrophically risky without effective antibiotics.
[Additional] India's NAP-AMR 2.0 (2025-2029) — GS3 (Health Policy / One Health):
Why India is acutely vulnerable:
- India is the world's largest consumer of antibiotics by volume — both in human medicine and as growth promoters in livestock and poultry
- Drug-resistant infections cause an estimated 70,000-1,00,000 deaths annually in India (WHO/ICMR estimates)
- Open-drain wastewater from pharmaceutical manufacturing clusters (Hyderabad's Patancheru-Bollaram, where much of the world's generic antibiotics are made) discharge antibiotic residues into rivers — creating environmental reservoirs of resistance genes
National Action Plan on AMR 2.0 (NAP-AMR 2.0):
- Launched: November 18, 2025 (World AMR Awareness Week, Nov 18-24, 2025)
- Succeeds NAP-AMR 1.0 (2017-2021); covers 2025-2029
- Lead Ministry: Ministry of Health and Family Welfare; cross-ministerial oversight by NITI Aayog
- Six pillars:
- Awareness and Education (public and prescriber)
- Surveillance and Laboratory Capacity (ICMR AMR Surveillance Network: 30 labs/hospitals)
- Antimicrobial Stewardship (rational prescribing; hospital infection control)
- Governance and Coordination
- Research and Innovation (new antibiotic development; diagnostics)
- One Health Integration — simultaneous action in human medicine, animal health, agriculture, and environment
One Health and AMR: One Health recognises that AMR is shared across humans, animals, and the environment — the same resistant bacteria circulate between farm animals (given antibiotics as growth promoters), slaughterhouses, water bodies, soil, and human hospitals. India's NAP-AMR 2.0 is its first plan to formally adopt the One Health framework — coordinating MoHFW, MoA (Agriculture), MoAHD (Animal Husbandry), MoEFCC (Environment), and ICMR in a single surveillance and response architecture.
UPSC angle: AMR is a high-frequency GS3 question — "India's approach to antimicrobial resistance," "One Health framework," "pharmaceutical pollution," "rational drug use." The cellular hook (70S ribosome → antibiotic → resistance mutation) connects this chapter directly to the policy response. NAP-AMR 2.0 (November 2025) is the latest and most comprehensive policy peg available for the 2026 exam cycle.
[Additional] 5b. Organ Donation — From Brain Death to NOTTO
The chapter references organ donation in its Mains strategy section but provides no actual framework on how India's organ donation system works. Brain death is a cellular/biological concept rooted directly in this chapter's content on cell death and irreversible cellular damage.
[Additional] India's Organ Donation Framework — GS2 (Health / Governance):
Brain Death — the cellular concept: Brain death = complete and irreversible cessation of all brain functions, including the brain stem, while the heart continues to beat (supported by ventilator). Cells in the cerebral cortex and brainstem have lost the ability to perform any biochemical function. Once diagnosed, the person is legally dead in India — but heart, kidneys, liver, lungs, pancreas, and corneas remain viable for a few hours to days (with intensive support) and can be transplanted.
Legal framework — THOTA 1994: The Transplantation of Human Organs and Tissues Act (THOTA), 1994 (amended 2011, 2014):
- Legally recognised brainstem death as death — enabling deceased-donor organ donation
- Prohibits commercial trading of organs (organ trafficking)
- Permits living donors: near relatives (parents, siblings, spouse, children) and, with Authorisation Committee approval, emotionally related donors
- Governs removal, storage, and transplantation of organs and tissues
NOTTO and the three-tier system:
| Level | Body | Function |
|---|---|---|
| National | NOTTO (National Organ and Tissue Transplant Organisation), New Delhi | Policy, allocation algorithms, national registry, waiting list |
| Regional | ROTTO (4 zones: North, South, East, West) | Zone-level allocation and coordination |
| State | SOTTO (State Organ and Tissue Transplant Organisation) | State hospital coordination; brain-death certification |
India's organ donation data (2024):
- Total transplants performed: 18,911 (2024) — up from just 4,990 in 2013; India is now 3rd globally in total transplants
- Deceased donors: ~1,000/year (vs ~180,000/year in USA — India's deceased donation rate is ~0.86 per million population vs USA's ~46 per million)
- Kidneys dominate: ~15,000 transplants/year; liver ~3,000; heart ~300
THOTA Amendment Rules 2025 and SC directives:
- THOTA (Amendment) Rules, 2025: Simplified corneal transplantation — removed mandatory clinical specular microscope requirement (a barrier for rural/smaller eye banks); aims to reduce the 25-lakh corneal blindness backlog
- Supreme Court (November 2025): Directed all states to establish SOTTOs; mandated national swap-transplant guidelines through NOTTO portal; required brain-stem death certification in all hospital death certificates
UPSC GS2 synthesis: India's 18,000+ transplants/year demonstrate policy success, but the deceased donation rate (0.86 per million vs global average ~13) reveals a massive unmet need driven by: religious/cultural hesitancy, low ICU penetration in small hospitals (brain death only diagnosed in ICUs), under-reporting of brain deaths, and fragmented SOTTO infrastructure. This is a classic GS2 governance-implementation gap question.
[Additional] 5b. mRNA Vaccines — Ribosomes in Public Health and India's Gennova HGCO19
The chapter covers cell organelles including the ribosome — the cellular machinery that synthesizes proteins by translating mRNA sequences. mRNA vaccines exploit exactly this mechanism: delivering synthetic mRNA into cells so ribosomes produce a viral protein that triggers immunity. India developed its own mRNA vaccine platform through Gennova Biopharmaceuticals under DBT's Mission COVID Suraksha.
Key Terms — mRNA Vaccines:
| Term | Meaning |
|---|---|
| mRNA (messenger RNA) | A single-stranded RNA molecule that carries the genetic instructions (copied from DNA in the nucleus) out to the ribosomes in the cytoplasm where proteins are synthesised |
| Ribosome | The cellular organelle (found in cytoplasm + rough ER) that reads mRNA sequences and assembles amino acids into proteins (translation); the key cell component exploited by mRNA vaccines |
| mRNA vaccine | A vaccine that delivers synthetic mRNA encoding a pathogen's protein (e.g., COVID-19 spike protein) into human cells; ribosomes translate this mRNA into the pathogen protein; the immune system recognises this protein and builds immunity; no live virus or DNA is used |
| Lipid nanoparticle (LNP) | The delivery vehicle for mRNA vaccines; a tiny fat bubble that protects the mRNA from degradation and helps it enter cells; key technology innovation enabling mRNA vaccines |
| Self-amplifying mRNA (saRNA) | An advanced mRNA platform where the mRNA carries genetic instructions to replicate itself inside the cell → lower dose needed vs conventional mRNA vaccine; India's Gennova HGCO19 uses this platform |
| DBT (Department of Biotechnology) | Under Ministry of Science and Technology; funded India's indigenous mRNA vaccine development via Mission COVID Suraksha |
[Additional] mRNA Vaccines — Cell Biology to Public Health and India's Indigenous Platform (GS3 — Science and Technology / Health):
How mRNA vaccines use the ribosome:
| Step | What happens | Cell biology concept |
|---|---|---|
| 1. Injection | mRNA (in lipid nanoparticle) injected into muscle | LNP protects mRNA from RNases |
| 2. Cell entry | LNP fuses with cell membrane → mRNA enters cytoplasm | Cell membrane → endocytosis |
| 3. Ribosome reads mRNA | Ribosomes in the cytoplasm bind to the synthetic mRNA and translate it into spike protein | Ribosome = protein synthesis factory |
| 4. Spike protein displayed | Spike protein is processed and displayed on the cell surface (via MHC molecules) | Endoplasmic reticulum + Golgi = protein processing + secretion |
| 5. Immune response | T cells and B cells recognise the spike protein → antibodies produced → memory cells formed | Immune system activation |
| 6. mRNA degraded | The synthetic mRNA is broken down within days (normal mRNA degradation pathway) — does NOT integrate into DNA | mRNA is temporary; nuclear DNA is untouched |
mRNA vaccine vs traditional vaccine — key differences:
| Feature | Traditional vaccine | mRNA vaccine |
|---|---|---|
| What is injected | Attenuated virus, inactivated virus, or viral protein | Synthetic mRNA (instructions, not the protein) |
| Contains live virus? | Sometimes (attenuated) | NO |
| Integrates into DNA? | NO | NO (mRNA cannot enter the nucleus) |
| Development speed | Years (growing virus in eggs) | Weeks (once genome is sequenced, mRNA can be synthesised) |
| Storage | Refrigerator temperature | Ultra-cold (−70°C for Pfizer/BioNTech; −20°C for some) |
| India example | Covaxin (inactivated virus, Bharat Biotech) | HGCO19 (Gennova Biopharmaceuticals) |
India's mRNA vaccine — HGCO19 (Gennova Biopharmaceuticals):
| Parameter | Detail |
|---|---|
| Vaccine name | HGCO19 |
| Developer | Gennova Biopharmaceuticals, Pune |
| Support | Department of Biotechnology (DBT) under Mission COVID Suraksha |
| Platform | Self-amplifying mRNA (saRNA) — mRNA contains replication machinery → lower dose needed; immune response from lower dose = safety advantage |
| Regulatory status | DCGI Phase I/II clinical trial clearance received; proceeded to further trials |
| Significance | India's first indigenous mRNA vaccine candidate; demonstrated domestic mRNA manufacturing capability |
| Formulation advantage | Gennova developed a thermostable formulation (stable at 2–8°C, not −70°C) — critical for India's supply chain |
Mission COVID Suraksha:
| Parameter | Detail |
|---|---|
| Launched | September 2020 |
| Ministry | Ministry of Science and Technology (DST + DBT) |
| Budget | ₹900 crore |
| Goal | Accelerate indigenous COVID-19 vaccine development |
| Key supported vaccines | HGCO19 (Gennova mRNA), Covaxin (Bharat Biotech inactivated), ZyCov-D (Zydus DNA vaccine) |
| ZyCov-D | World's first approved DNA vaccine for COVID-19; approved by DCGI August 2021; needle-free administration |
BioE3 Policy 2024 — future of biotechnology:
- Cabinet approved BioE3 Policy (Biotechnology for Economy, Environment, and Employment) in August 2024
- Promotes high-performance biomanufacturing, sustainable agriculture, healthcare products including mRNA platforms
- DBT implementing; connects to Gennova's mRNA work and India's ambition to become a global biopharmaceutical hub
UPSC synthesis: Key exam facts: mRNA vaccines use ribosomes to translate synthetic mRNA into viral protein → immune response; mRNA does NOT integrate into DNA (stays in cytoplasm; nucleus untouched); India's first mRNA vaccine candidate = HGCO19 by Gennova Biopharmaceuticals, Pune = self-amplifying mRNA (saRNA) platform = DBT funded under Mission COVID Suraksha; BioE3 Policy = August 2024 = Cabinet approved = DBT. Prelims trap: mRNA vaccines do NOT alter DNA (mRNA cannot cross the nuclear membrane to reach DNA); Covaxin = inactivated virus (NOT mRNA) = Bharat Biotech; ZyCov-D = DNA vaccine = Zydus = needle-free = world's first approved DNA vaccine; HGCO19 = mRNA vaccine = Gennova = Pune; DBT is under Ministry of Science and Technology (NOT Ministry of Health — health is MoHFW); the mRNA degradation means the vaccine instructions are temporary (a few days) — this is a safety feature, not a weakness.
Exam Strategy
Prelims traps:
- Virchow added the third proposition to cell theory; do not attribute all three to Schleiden/Schwann.
- Prokaryotes have 70S ribosomes; eukaryotes have 80S — antibiotics exploit this difference.
- Mitochondria and chloroplasts both have their own DNA and 70S ribosomes.
- Centrosomes are absent in most plant cells (not all) — they are present in lower plants like mosses.
- Osmosis is diffusion of water through a semi-permeable membrane — not diffusion of solutes.
Mains frameworks:
- On GMO and gene editing: "The cell nucleus, as the repository of the genetic blueprint, is both the site of natural variation and the target of deliberate biotechnological intervention."
- On antibiotic resistance: Connect ribosome structure differences (70S vs 80S) to how antibiotics work and why AMR is a global health emergency.
- On organ donation policy: Connect cell death, tissue viability windows, and the need for rapid organ harvest to policy gaps in India's organ donation infrastructure.
Practice Questions
Q1 (Prelims 2019): With reference to the recent developments in science, which one of the following statements is not correct? (Options included a reference to CRISPR-Cas9 gene editing) Relevance: CRISPR targets the nucleus/DNA — directly rooted in cell biology.
Q2 (Mains GS3 2017): "The agricultural sector in India is plagued by inadequate research and lack of modern biotechnology adoption." Discuss the role of GM crops and the regulatory framework governing their approval in India. Cell biology link: GM crops involve inserting foreign DNA into the plant cell nucleus — requires understanding of nucleus and DNA.
Q3 (Prelims 2016): Regarding "Stem Cells" frequently in the news, which of the following statements is/are correct? Relevance: Stem cells are undifferentiated cells (no specialised organelles yet) — rooted in cell differentiation concepts.
Q4 (Mains GS2 2020): Discuss the ethical dimensions of organ transplantation in India. What policy reforms are needed to increase organ donation rates? Cell biology link: Organ viability after cell death, cold ischaemia time, tissue matching — all require understanding of cellular function.
BharatNotes